Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at olaparib and abiraterone for prostate cancer (PROpel)

Overview

Cancer types:

Prostate cancer, Secondary cancers

Status:

Closed

Phase:

Phase 3

Details

This trial is for people with metastatic castration resistant prostate cancer (mCRPC). This means that the cancer:

  • has spread to other parts of the body

  • got worse despite having hormone treatment

It is for people who are going to have treatment for metastatic resistant prostate cancer for the first time.

Recruitment start: 1 December 2018

Recruitment end: 31 January 2020

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Noel Clarke

Supported by

AstraZeneca

Last reviewed: 03 Feb 2020

CRUK internal database number: 15962

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Find a Clinical Trial

Search our clinical trials database for all cancer trials and studies recruiting in the UK.

An icon of two speech bubbles, indicating a conversation.

Cancer Chat forum

Connect with other people affected by cancer and share your experiences.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.